Today, developers of innovative medical devices are increasingly utilizing artificial intelligence (AI) and machine learning (ML) technologies to derive important insights with the promise of transforming the delivery of healthcare. Yet, concerns regarding the transparency of AI/ML-enabled devices, or the degree to which information about such devices is communicated to stakeholders, threatens not only perceptions
Latest Post
More Posts
Promotion of Devices Subject to the FDA’s COVID-19 Enforcement Policies
Subscribe: Subscribe via RSS
Firm/Org